透景生命：10月22日召开董事会会议

Group 1 - The core point of the article is that TuoJing Life (SZ 300642) held its fourth board meeting on October 22, 2025, to review the proposal for the third quarter report of 2025 [1] - TuoJing Life's revenue composition for the year 2024 is entirely from the in vitro diagnostics industry, accounting for 100.0% [1] - As of the report, TuoJing Life has a market capitalization of 4.2 billion yuan [1]